Diogo Rau

Yes. You can't be certain, of course, that anything is going to be approved. And so we apply a probability of technical success. This phrase I'd never heard of before I got here, but every step of the way has probability of technical success. And so you factor it in and you take all that into account. But you know when you have a good medicine and you know what it's going to take.

Yes. You can't be certain, of course, that anything is going to be approved. And so we apply a probability of technical success. This phrase I'd never heard of before I got here, but every step of the way has probability of technical success. And so you factor it in and you take all that into account. But you know when you have a good medicine and you know what it's going to take.

But it just takes 10 years to bring a medicine to life. And I don't think that was one of the things that I realized before I came into this, just how long it takes and how much money it takes. So it is possible that you will work on things that you will never see come to fruition? In fact, most of our scientists that work here will never see their medicines that they're working on come to life.

But it just takes 10 years to bring a medicine to life. And I don't think that was one of the things that I realized before I came into this, just how long it takes and how much money it takes. So it is possible that you will work on things that you will never see come to fruition? In fact, most of our scientists that work here will never see their medicines that they're working on come to life.

which is kind of crazy to think of. How does that affect the culture of an organization? It gives it a really long-term perspective, like a crazy long-term perspective.

which is kind of crazy to think of. How does that affect the culture of an organization? It gives it a really long-term perspective, like a crazy long-term perspective.

When we're talking about things, making decisions, we're really not thinking, you know, like in an executive committee level, there are some things that we're doing on a this-year basis, but there are a lot of things that we're doing that we're really talking about like the 2030s, like just... just a much different time scale from anything else.

When we're talking about things, making decisions, we're really not thinking, you know, like in an executive committee level, there are some things that we're doing on a this-year basis, but there are a lot of things that we're doing that we're really talking about like the 2030s, like just... just a much different time scale from anything else.

And so we're not going to do anything stupid, I think is one of the good things. We're not going to trade off some of the long term to get a little bit of benefit in the short term. So I think it makes us much more rational that way. I guess I would say we play the long game.

And so we're not going to do anything stupid, I think is one of the good things. We're not going to trade off some of the long term to get a little bit of benefit in the short term. So I think it makes us much more rational that way. I guess I would say we play the long game.

My boss, our CEO, gave me a mandate to really change, to bring in technology into everything that we did. So it was not a caretaker role sort of a mandate. We want you to just keep running the things. We want you to really figure out what can you do to shake things up. And so that was really the goal. And I think a big part of it was bringing a consumer orientation as well.

My boss, our CEO, gave me a mandate to really change, to bring in technology into everything that we did. So it was not a caretaker role sort of a mandate. We want you to just keep running the things. We want you to really figure out what can you do to shake things up. And so that was really the goal. And I think a big part of it was bringing a consumer orientation as well.

And I think this is an industry that has largely worked the same since the 1950s. I mean, if you look at it, the way you get medicines today as a patient is basically unchanged. You go to your doctor, they write a form. Maybe now they submit your prescription electronically. You still have to make sure you can pay for it. You still have to go to a retail pharmacy in most cases.

And I think this is an industry that has largely worked the same since the 1950s. I mean, if you look at it, the way you get medicines today as a patient is basically unchanged. You go to your doctor, they write a form. Maybe now they submit your prescription electronically. You still have to make sure you can pay for it. You still have to go to a retail pharmacy in most cases.

None of that's really changed since the 1950s, even though we have so much more. So a big part of what we're trying to do is actually... A big part of my mandate is to really bring this into the 21st century, or at least the late 20th century.

None of that's really changed since the 1950s, even though we have so much more. So a big part of what we're trying to do is actually... A big part of my mandate is to really bring this into the 21st century, or at least the late 20th century.

I mean, what's the kind of remit? The great thing is that I get to focus on all of that stuff. So everything that's technology related. I do cover everything from the discovery side through the consumer side. And actually, those are probably some of my favorite parts. Because, of course, I shouldn't be saying favorites.

I mean, what's the kind of remit? The great thing is that I get to focus on all of that stuff. So everything that's technology related. I do cover everything from the discovery side through the consumer side. And actually, those are probably some of my favorite parts. Because, of course, I shouldn't be saying favorites.

But I love the discovery side and discovering new molecules and what we can do there. A lot of cool stuff, especially with AI, we could talk for hours about. And the consumer side is also the place where I see, where I have a passion coming from my prior life at Apple and just seeing the potential we have to change everything there.

But I love the discovery side and discovering new molecules and what we can do there. A lot of cool stuff, especially with AI, we could talk for hours about. And the consumer side is also the place where I see, where I have a passion coming from my prior life at Apple and just seeing the potential we have to change everything there.